Frankfurt - Delayed Quote EUR
Pentixapharm Holding AG (PTP.F)
2.8500
+0.0700
+(2.52%)
As of 8:02:15 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
103
24
31
59
Cost of Revenue
-4,281
-4,696
-3,940
-2,540
Gross Profit
4,384
4,720
3,971
2,599
Operating Expense
10,521
10,881
6,147
4,241
Operating Income
-6,137
-6,161
-2,176
-1,642
Net Non Operating Interest Income Expense
51
-53
--
-1
Pretax Income
-6,086
-6,214
-779
-1,730
Tax Provision
1,302
1,425
1,182
762
Net Income Common Stockholders
-7,388
-7,639
-1,961
-2,492
Diluted NI Available to Com Stockholders
-7,388
-7,639
-1,961
-2,492
Basic EPS
-0.30
-0.31
-0.08
-0.10
Diluted EPS
-0.30
-0.31
-0.08
-0.10
Basic Average Shares
24,795.4770
24,795.4770
24,795.4770
24,795.4770
Diluted Average Shares
24,795.4770
24,795.4770
24,795.4770
24,795.4770
Total Expenses
6,240
6,185
2,207
1,701
Net Income from Continuing & Discontinued Operation
-7,388
-7,639
-1,961
-2,492
Normalized Income
-7,388
-7,639
-1,961
-2,492
Interest Income
328
130
--
--
Interest Expense
277
183
--
1
Net Interest Income
51
-53
--
-1
EBIT
-5,809
-6,031
-779
-1,729
EBITDA
-5,666
-5,884
-665
-1,623
Reconciled Cost of Revenue
-4,281
-4,696
-3,940
-2,540
Reconciled Depreciation
143
147
114
106
Net Income from Continuing Operation Net Minority Interest
-7,388
-7,639
-1,961
-2,492
Normalized EBITDA
-5,666
-5,884
-665
-1,623
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
12/31/2021 - 10/3/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade